BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15592707)

  • 1. [Chemotherapy for germ cell cancer].
    Beyer J; Bokemeyer C
    Urologe A; 2004 Dec; 43(12):1507-13. PubMed ID: 15592707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evidence based medicine indications for radiation therapy in testicular germ cell tumours].
    Souchon R; Classen J; Schmidberger H
    Urologe A; 2004 Dec; 43(12):1500-6. PubMed ID: 15502911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor].
    Heidenreich A; Krege S; Flasshove M
    Urologe A; 2004 Dec; 43(12):1521-30. PubMed ID: 15592709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of testicular cancer].
    Krege S; Hartmann JT; Rübben H
    Urologe A; 2006 May; 45(5):600-4. PubMed ID: 16612645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
    Kollmannsberger C; Rick O; Derigs HG; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer HG; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C
    J Clin Oncol; 2002 Apr; 20(8):2031-7. PubMed ID: 11956262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for clinical stage I nonseminomatous germ cell tumours.
    Vaughn DJ
    BJU Int; 2009 Nov; 104(9 Pt B):1381-6. PubMed ID: 19840017
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of post-chemotherapy surgery in germ cell tumors.
    Sim HG; Lange PH; Lin DW
    Urol Clin North Am; 2007 May; 34(2):199-217; abstract ix. PubMed ID: 17484925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
    Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
    BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
    Kondagunta GV; Motzer RJ
    Urol Clin North Am; 2007 May; 34(2):179-85; abstract ix. PubMed ID: 17484923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
    Vaughn DJ
    Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the postchemotherapy residual mass.
    Sheinfeld J; Bajorin D
    Urol Clin North Am; 1993 Feb; 20(1):133-43. PubMed ID: 8381994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dose chemotherapy for advanced testicular germ cell tumors].
    Miyake H; Fujisawa M
    Hinyokika Kiyo; 2012 Dec; 58(12):731-5. PubMed ID: 23328175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of MDR1-expression in testicular germ cell cancer.
    Schrader AJ; Seger M; Konrad L; Olbert P; Hegele A; Hofmann R; Heidenreich A
    Exp Oncol; 2007 Sep; 29(3):212-6. PubMed ID: 18004247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of metastatic germ cell cancers].
    Timsit MO; Lebret T; Lugagne PM; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S376-81. PubMed ID: 19070818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.